Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.
about
PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cellsMotexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductaseAntioxidant activity of Coriandrum sativum and protection against DNA damage and cancer cell migrationArsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1.Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanismsMitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculataPhase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignanciesAutophagic programmed cell death by selective catalase degradation.Bismuth- and lead-texaphyrin complexes: towards potential α-core emitters for radiotherapy.Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress.Cinnamomum cassia Suppresses Caspase-9 through Stimulation of AKT1 in MCF-7 Cells but Not in MDA-MB-231 Cells.State of the art chemotherapeutic management of pediatric brain tumors.Motexafin gadolinium injection for the treatment of brain metastases in patients with non-small cell lung cancer.Reactive oxygen species: an Achilles' heel of melanoma?The novel expanded porphyrin, motexafin gadolinium, combined with [90Y]ibritumomab tiuxetan for relapsed/refractory non-Hodgkin's lymphoma: preclinical findings and results of a phase I trial.Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.Oxidative stress and proteasome inhibitors in multiple myeloma.Antioxidant enzyme inhibitor role of phosphine metal complexes in lung and leukemia cell lines.Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy?Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.Small molecule CP-31398 induces reactive oxygen species-dependent apoptosis in human multiple myelomaInterfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin.Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.
P2860
Q24654958-0C4FB45E-4EF3-40B3-AC2D-271CD8A91949Q28567883-4E57FFAE-E38A-445C-8FA3-88F8249497D1Q33641106-2DB3CDD2-BFEA-4C6E-83A2-5878DA08B20DQ33862077-E4A29AAD-7983-497A-9A88-8BEFF5554E93Q34020461-D2EC963E-CE01-4AEF-BE88-6E04AAFC08BBQ34168689-12B2DDA2-4006-4D24-AF3E-7F4446DAE86EQ34570658-DB03C6D7-55D8-4674-A0D7-EEA467B50565Q34596715-E39B2CBC-58D6-4736-AD8F-4E4008F94916Q35401128-8E131B5F-1493-4D41-8F37-361281F5A77FQ35750893-7F5BE00F-8004-4E43-B7CE-A54FAF6C0D42Q35877624-23A674C6-0703-4E04-9BC4-AB9D35F0A1C2Q36492376-690A4C4C-FFD7-40C5-AD91-8496CDC4204CQ36920440-76E77016-86DD-4EE5-91C1-3C9C4F159A77Q37316983-71D06B19-2198-42F1-8502-A0C92EE0B5D1Q37390535-CFB6C428-9EA0-4467-A839-EF1C0E987256Q37488026-1AAC7B26-3D4A-4C4B-9855-FC235F8FF90FQ38717135-BFFCB555-119C-4A16-88DD-10550E51DE25Q38917659-D93D2CE0-20E8-4857-B6E3-0A1D3B096CA1Q39380445-B3A51807-A24D-40F2-A72C-3FC3F357F026Q39664565-F66D4818-DFF3-4A89-BF58-0412881B6A12Q39699466-86D09A3F-15E3-4CB2-9E5D-C5DA80C374D3Q42371593-10D5A7BD-3FCC-45C8-89B7-E5714BF6C343Q42875767-478CB186-BB6C-40C7-9D1D-A6761B331059Q54712992-A9830872-E289-4E0F-84C8-840BAE29D6F5
P2860
Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Motexafin gadolinium generates ...... istant multiple myeloma cells.
@en
type
label
Motexafin gadolinium generates ...... istant multiple myeloma cells.
@en
prefLabel
Motexafin gadolinium generates ...... istant multiple myeloma cells.
@en
P2093
P1433
P1476
Motexafin gadolinium generates ...... istant multiple myeloma cells.
@en
P2093
Andrew M Evens
Darren Magda
Jeff Nelson
Philip Lecane
Richard A Miller
Ronald B Gartenhaus
Seema Singhal
Sheila Prachand
P304
P356
10.1182/BLOOD-2004-03-0964
P407
P50
P577
2004-09-23T00:00:00Z